Auro Vaccines LLC
Pearl River, NY Auro Vaccines LLC
- UEI
- JCL5JKNMYAU5
- CAGE
- 8EWB4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 401 N Middletown Rd Bldg 205F, Pearl River, NY 10965, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Advanced development of multivalent vaccine candidates for filovirus and lassa fever | National Institute of Allergy and Infectious Diseases | $10,706,003 |
About Auro Vaccines LLC
Auro Vaccines LLC is a foreign owned, for-profit organization that provides vaccine development and manufacturing services to the U.S. government. Through prime federal contracts, Auro Vaccines conducts advanced development of multivalent vaccine candidates for filoviruses and Lassa fever. A $25.2 million contract was awarded in 2020 by the National Institute of Allergy and Infectious Diseases to support a six-year effort concluding in 2026 for vaccine development work performed in Baltimore, Maryland.
As a subcontractor under federal grants, Auro Vaccines has focused its vaccine development work on viral hemorrhagic fevers and henipaviruses. This includes constructing and testing recombinant vesicular stomatitis virus vectored vaccine candidates against Ebola virus species, Marburg virus, Crimean-Congo hemorrhagic fever virus, and Nipah and Hendra viruses. Prime grant partners have included the University of Texas Medical Branch at Galveston and The Henry M. Jackson Foundation for the Advancement of Military Medicine.
Through both prime contracts and subawards under federal grants, Auro Vaccines provides specialized services in viral vaccine construct development, immunogenicity and efficacy testing, and early stage manufacturing process development. Its work supports U.S. government efforts to effectively respond to emerging epidemic viral diseases as well as potential biological threats.
Quick answers
What is Auro Vaccines LLC's UEI?
Auro Vaccines LLC's Unique Entity ID (UEI) in SAM.gov is JCL5JKNMYAU5.
What is Auro Vaccines LLC's CAGE code?
Auro Vaccines LLC's CAGE code is 8EWB4.
What is Auro Vaccines LLC's primary NAICS code?
Auro Vaccines LLC's primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Auro Vaccines LLC located?
Auro Vaccines LLC's physical address in SAM.gov is 401 N Middletown Rd Bldg 205F, Pearl River, NY 10965, USA.
Is Auro Vaccines LLC registered in SAM.gov?
Yes. Auro Vaccines LLC's SAM.gov registration is active through March 13, 2027.
What is Auro Vaccines LLC's most recent federal award?
Auro Vaccines LLC's most recent federal contract award is Advanced development of multivalent vaccine candidates for filovirus and lassa fever (75N93020C00040), from National Institute of Allergy and Infectious Diseases, on July 21, 2020.
On GovTribe
See Auro Vaccines LLC's full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors